International Workshop on Patient Safety and Drug Detection Technology

Transcription

1 International Workshop on Patient Safety and Drug Detection Technology Silver Oak, India Habitat Centre, Lodhi Road, New Delhi, India AGENDA DAY 1: Monday, September 10, :30-9:30 Registration 9:30-10:40 Inaugural Session Welcome Address: Mr. Wajahat Habibullah, PSM India & Former Secretary to the Government of India Setting the Agenda & Objectives: Dr. Arun Kumar Panda, Joint Secretary to the Government of India, Ministry of Health & Family Welfare Special Address: Dr. Nata Menabde, WHO Representative to India Special Address: Mr. R. K. Jain, AS&DG, Government of India, Ministry of Health & Family Welfare Special Address: Dr. Jagdish Prasad, Director General of Health Services, Government of India Keynote address: Shri P. K. Pradhan, Secretary to the Government of India, Ministry of Health & Family Welfare Inaugural Address: Shri Sudip Bandyopadhyay, Hon ble Minister of State for Health & Family Welfare, Government of India Vote of Thanks: Mr. Bejon Misra, Founder Director, Partnership for Safe Medicines (PSM) India 10:40-11:10 Tea and Coffee Break 11:10-01:00 Technical Session I: Challenges on Accessibility of Quality Medicines & Using Detection Technology 01:00-2:00 Lunch Session Chairperson: Dr. G. N. Singh, Drug Controller General of India Dr. D. Roy, Deputy Drug Controller, CDSCO, India Dr. Michael Deats, Project Manager, SSFFC Monitoring Project, Quality Assurance & Safety: Medicines, World Health Organization Ms. Lim Chin Chin, Director, Health Sciences Authority, Forensic Laboratory Singapore John Kauffman, Research Chemist, USFDA, CDER Dr. Cathie Karch Vielle, EDQM, Council of Europe Dr. Supanee Duangteraprecha, Thailand, Ministry of Public Health, Senior Pharmacist, Bureau of Drug and Narcotics, Department of Medical Sciences Dr. Praful Naik, Chief Scientific Officer, Bilcare India Page 1 of 5

2 2:00-3:30 Technical Session II: Regulatory Perspectives on Patient Safety Session Chairperson: Dr. Arun Kumar Panda, Joint Secretary to the Government of India, Ministry of Health & Family Welfare Dr. Jaga Shetty, Drug Controller of Karnataka, India Dr. Stephan Fuehring, Directorate General, European Commission, Health and Consumer Lucinda Buhse, Director, Division of Pharmaceutical Analysis, CDER, USFDA Mr. Ravi Mathur, CEO India, GS1 India Mr. D. G. Shah, President, Indian Pharmaceutical Alliance Shaba Mohammed, Assistant Director, Ports Inspection, Directorate, National Agency for Food and Drug Administration, NAFDAC, Nigeria Mr. Gajanan Wakankar, Executive Director, IDMA Ms. Leena Menghaney, Access Campaign India Coordinator, Medecins Sans Frontieres 3:30-4:00 Tea & Coffee Break 4:00-5:30 Technical Session III: Detection Technologies as Part of a Larger Strategy for Drug Authentication Quality Session Chairperson: Dr. Surinder Singh, Director, National Institute Biologicals, India Mr. Andreas Seiter, Senior Health Specialist, The World Bank Mr. Jeffrey Gren, Director, Office of Health and Consumer Goods, U.S. Department of Commerce Dr. Amit Sen Gupta, Peoples Health Movement, India Dr. Madhur Gupta, Technical Officer, Pharmaceuticals, WHO- India Country Office Rasiah Sivalingam, Regulatory Consultant, Singapore Health Sciences Authority, Product Quality Sampling (PQS) Program Mrs. Ati Setiawati, Head Division for Therapeutic Product and Hazardous Substances - NADFC Indonesia Reception Dinner at the India Habitat Centre at 7.30 PM for All Delegates at Jacaranda Hall. Page 2 of 5

3 DAY 2: Tuesday, September 11, : am Technical Session IV: Early Detection Technologies for better Quality Medicines and Role of Serialization 11:30-12:00 Tea/Coffee Break Session Chairperson: Shri C. P. Singh,Chairman, National Pharmaceutical Pricing Authority (NPPA), India Dr. Vishwajeet Ringe, Senior Technical Director, National Informatics Centre (NIC), India Mr. Ulrike Kreysa, GS1, Vice President Healthcare, France Ms. Jesica Carino, ANMAT, Argentina Mr. Ajit Shetty, Chairman Emeritus Janssen Pharmaceutical, Corporate Vice President-Enterprise Supply Chain (Retd.) Johnson and Johnson Dr. H. Koshia, Commissioner FDA Gujarat (INDIA) Mr. Gopa Kumar, Third World Network Mr. A. S. Krishna, Head Global Corporate Affairs, Ranbaxy Limited Mr. Lalit Kumar Jain, All India SME Pharma Manufacturers Association (AISPMA) 12:00-1:30 pm WAY FORWARD: Developing Roadmap for Enhancing Patient Safety & Drug Quality Facilitators: Shri Arun Kumar Panda, Joint Secretary, Ministry of Health& Family Welfare Dr. Raja Sekhar Vundru, Joint Secy., Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers. Mr. Sanjay Prasad, Director (Drug), Ministry of Health & Family Welfare Dr. G. N. Singh DCGI and Dr. V. G. Somani, Deputy Drug Controller of India Dr. Michael Deats and Dr. Madhur Gupta, World Health Organization (WHO) Mr. Bejon Misra, Partnership for Safe Medicines (PSM) India CLOSURE FOLLOWED WITH LUNCH Page 3 of 5

4 9/06/12 International Cooperation on Criminal Investigations Related to Spurious Medicines in the Global Supply Chain Silver Oak Hall, India Habitat Centre, Lodhi Road, New Delhi, India 11 th September, 2012 Organized By FICCI CASCADE & PSM India Final Program Guide 2:00-2:10 pm Opening Comments Mr. Anil Rajput, Chairman, FICCI CASCADE Mr. Jeffrey Gren, Director, Office of Health and Consumer, Goods, U.S. Department of Commerce 2:10-3:25 pm Global Overview of Spurious Medicines, Criminal Investigations and Best Practices Chairperson: Aline Plancon, Director MPCPC, INTERPOL Shaba Mohammed, Assistant Director, Ports Inspection, Directorate, National Agency for Food and Drug Administration, NAFDAC, Nigeria Rasiah Sivalingam, Regulatory Consultant, Singapore Health Sciences Authority, Product Quality Sampling (PQS) Program Raymond Velez, Eli Lilly, Regional Manager, Global Product Protection, Asia Pacific 3:25-3:45 pm Coffee Break 3:45-5:15 pm Cooperation of Law Enforcement, Customs and Industry and Public Private Partnerships Related to Spurious Medicines, Criminal Investigations Chairperson: Ms. Kalpana Reddy, First Secretary, U.S. Embassy Delhi Kishore Kar, Vice President, PharmaSecure India William Rawlins, Regional Security Director, Office of Middle East Cluster, Novartis India Law Enforcement Representative MacKay Spears, Deputy Attache New Delhi; U.S. Immigration and Customs Enforcement (ICE) Representative from IPA and IDMA Page 4 of 5

5 5:15-5:30 pm Closing Comments Government of India Officials Mr. P.C. Jha Advisor FICCI CASCADE, Ex Chairman CBEC Page 5 of 5